T. Rowe Price Associates
SOLV icon

T. Rowe Price Associates’s Solventum SOLV Stock Holding History

T. Rowe Price Associates’s Portfolio SOLV Stock Details SOLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7M Buy
216,340
+455
+0.2% +$33.2K ﹤0.01% 1193
2026
Q1 		$14.1M Sell
215,885
-683
-0.3% -$50.7K ﹤0.01% 1132
2025
Q4 		$17.2M Buy
216,568
+657
+0.3% +$50.3K ﹤0.01% 1094
2025
Q3 		$15.8M Buy
215,911
+14,904
+7% +$1.09M ﹤0.01% 1116
2025
Q2 		$15.2M Sell
201,007
-34
-0% -$2.41K ﹤0.01% 1019
2025
Q1 		$15.3M Buy
201,041
+499
+0.2% +$37.2K ﹤0.01% 1017
2024
Q4 		$13.2M Buy
200,542
+770
+0.4% +$53.9K ﹤0.01% 1086
2024
Q3 		$13.9M Sell
199,772
-292
-0.1% -$17.6K ﹤0.01% 1073
2024
Q2 		$10.6M Buy
200,064
+115,391
+136% +$7M ﹤0.01% 1102
2024
Q1 		$5.89M Buy
+84,673
New +$6.34M ﹤0.01% 1186

Other funds holding SOLV

IFP
Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TFM
Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates's SOLV Position: Q2 2026 in Review

T. Rowe Price Associates increased its Solventum (SOLV) stake by 0.21% in Q2 2026, buying an estimated $33.2K and bringing the position to 216,340 shares worth $16.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

T. Rowe Price Associates first reported a position in SOLV in Q1 2024 and has held it in 10 quarters since. The position peaked at $17.2M in Q4 2025. 885 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • T. Rowe Price Associates held 216,340 shares of Solventum worth $16.7M as of Q2 2026.
  • T. Rowe Price Associates bought 455 Solventum shares in Q2 2026, an estimated $33.2K.
  • Solventum made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1193 holding.
  • T. Rowe Price Associates first reported a position in Solventum in Q1 2024 and has held it in 10 quarters since.
  • T. Rowe Price Associates's Solventum position peaked at $17.2M in Q4 2025.
  • 885 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.